BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 26832)

  • 21. Isolation of heat-stable glucocerebrosidase activators from the spleens of three variants of Gaucher's disease.
    Peters SP; Coffee CJ; Glew RH; Lee RE; Wenger DA; Li SC; Li YT
    Arch Biochem Biophys; 1977 Sep; 183(1):290-7. PubMed ID: 907355
    [No Abstract]   [Full Text] [Related]  

  • 22. Normal acid-phosphatase and angiotensin converting enzyme activities in serum of a patient with Gaucher's disease.
    Daniels LB; Robinson DB; Glew RH; Wylin RF
    Clin Chem; 1981 Oct; 27(10):1782-3. PubMed ID: 6269780
    [No Abstract]   [Full Text] [Related]  

  • 23. Elevated serum and spleen angiotensin converting enzyme and serum lysozyme in Gaucher's disease.
    Silverstein E; Friedland J
    Clin Chim Acta; 1977 Jan; 74(1):21-5. PubMed ID: 188566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The occurrence of two immunologically distinguishable beta-glucocerebrosidases in human spleen.
    Aerts JM; Donker-Koopman WE; van der Vliet MK; Jonsson LM; Ginns EI; Murray GJ; Barranger JA; Tager JM; Schram AW
    Eur J Biochem; 1985 Aug; 150(3):565-74. PubMed ID: 4018098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Separation of tissue and serum acid phosphatase isoenzymes by ion-exchange column chromatography.
    Mercer DW
    Clin Chem; 1977; 23(4):653-8. PubMed ID: 844161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthetic substrate beta-glucosidase activity in leukocytes: a reproducible method for the identification of patients and carriers of Gaucher's disease.
    Wenger DA; Clark C; Sattler M; Wharton C
    Clin Genet; 1978 Feb; 13(2):145-53. PubMed ID: 23912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isoenzymes of human prostate acid phosphatase.
    Chu TM; Wang MC; Merrin C; Valenzuela L; Murphy GP
    Oncology; 1978; 35(5):198-200. PubMed ID: 724198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of N-acyl phosphatidylethanolamines with different N-acyl groups as activators of glucocerebrosidase in various forms of Gaucher's disease.
    Basu A; Prence E; Garrett K; Glew RH; Ellingson JS
    Arch Biochem Biophys; 1985 Nov; 243(1):28-34. PubMed ID: 3933429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue acid hydrolase activities in Gaucher's disease.
    Ockerman PA; Köhlin P
    Scand J Clin Lab Invest; 1968; 22(1):62-4. PubMed ID: 5706652
    [No Abstract]   [Full Text] [Related]  

  • 30. [Separation by electrofocusing of the molecular forms of splenic beta-glucosidase in normal subjects and Gaucher's disease].
    Maret A; Salvayre R; Nègre A; Douste-Blazy L
    Biomedicine; 1980 May; 33(3):82-6. PubMed ID: 6778520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple forms of membrane-bound beta-glucosidase in Gaucher's disease.
    Yaqoob M; Carroll M
    Clin Genet; 1981 Aug; 20(2):161-7. PubMed ID: 6796311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro culture of spleen cells from a case of Gaucher's disease.
    Fraccaro M; Magrini U; Scappaticci S; Zacchello F
    Ann Hum Genet; 1968 Oct; 32(2):209-13. PubMed ID: 4304418
    [No Abstract]   [Full Text] [Related]  

  • 33. Tartrate-resistant, purple acid phosphatase in Gaucher cells of the spleen. Immuno- and cytochemical analysis.
    Schindelmeiser J; Radzun HJ; Münstermann D
    Pathol Res Pract; 1991 Mar; 187(2-3):209-13. PubMed ID: 2068001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activators of spleen glucocerebrosidase from controls and patients with various forms of Gaucher's disease.
    Basu A; Glew RH; Daniels LB; Clark LS
    J Biol Chem; 1984 Feb; 259(3):1714-9. PubMed ID: 6693432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of rates of hydrolysis of N-oleoyl and N-stearoyl glucocerebroside in patients with Gaucher's disease.
    Peters SP; Aquino L; Naccarato WF; Gilbertson JR; Diven WF; Glew RH
    Biochim Biophys Acta; 1979 Oct; 575(1):27-36. PubMed ID: 508779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acid hydrolases in leukocytes and platelets of normal subjects and in patients with Gaucher's and Fabry's disease.
    Beutler E; Kuhl W; Matsumoto F; Pangalis G
    J Exp Med; 1976 Apr; 143(4):975-80. PubMed ID: 3620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathology of Gaucher's disease.
    Kahn LB
    S Afr Med J; 1974 Jun; 48(26):1098-102. PubMed ID: 4843491
    [No Abstract]   [Full Text] [Related]  

  • 38. Gaucher's disease in the Cape coloured population of the RSA, including a family with 5 affected siblings.
    Swart AL; Hesseling PB; Hayden MR; Louw M; Herbert JS
    S Afr Med J; 1987 Jan; 71(2):97-9. PubMed ID: 3101207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [HISTOCHEMICAL AND BIOCHEMICAL INVESTIGATIONS IN GAUCHER'S DISEASES].
    CZITOBER H; GRUENDIG E; SCHOBEL B
    Klin Wochenschr; 1964 Dec; 42():1179-84. PubMed ID: 14339428
    [No Abstract]   [Full Text] [Related]  

  • 40. Biochemical properties of the tartrate-resistant acid phosphatase activity in Gaucher disease.
    Lam KW; Desnick RJ
    Prog Clin Biol Res; 1982; 95():267-78. PubMed ID: 6750653
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.